Fortress Biotech (FBIO)
(Delayed Data from NSDQ)
$1.63 USD
+0.02 (1.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $1.63 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Price, Consensus and EPS Surprise
FBIO 1.63 +0.02(1.24%)
Will FBIO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for FBIO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for FBIO
Fortress Biotech (FBIO) Shows Fast-paced Momentum But Is Still a Bargain Stock
Fortress Biotech (FBIO) Reports Q2 Loss, Lags Revenue Estimates
FBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates
UniQure (QURE) Reports Q2 Loss, Tops Revenue Estimates
Here Is Why Bargain Hunters Would Love Fast-paced Mover Fortress Biotech (FBIO)
Other News for FBIO
Fortress Biotech files to sell 6.19M shares of common stock for holders
Biotech Alert: Searches spiking for these stocks today
Fortress Biotech files to sell 6.19M shares of common stock for holders
Video: Thursday 9/26 Insider Buying Report: FBIO, AXR
Fortress Biotech to Participate in October 2024 Investor Conferences